NasdaqGS:ALNYBiotechs
Assessing Alnylam Pharmaceuticals (ALNY) Valuation After Mixed Share Performance And Strong AMVUTTRA Uptake
What recent price moves tell you about Alnylam Pharmaceuticals (ALNY)
Alnylam Pharmaceuticals (ALNY) has drawn investor attention after a period of mixed share performance, with the stock down over the past month and past 3 months but slightly higher over the past year.
See our latest analysis for Alnylam Pharmaceuticals.
At a share price of US$297.45, Alnylam’s short term share price return has been weak, with the stock down year to date. Longer term total shareholder returns over 3 and 5...